A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Inclusion Criteria: * Male or Female patients from 20 years to 75 years of age when signing Informed Consent. * Diagnosed as having RA according to the revised 1987 ACR criteria for at least 6 months prior to screening * Patients who have inadequate response to MTX administered for at least 12 weeks before the beginning of screening period and on a stable dose. Exclusion Criteria: * patients with active tuberculosis or latent tuberculosis based on current clinical symptoms, chest X-ray test and IFN-γ release assay at screening * patients with any of the following concomitant diseases and/or history within 24 weeks before the first administration of investigational products in this study; Serious infectious disease, Opportunistic infection, Chronic or recurrent infectious disease * patients with any seropositive result for hepatitis B or hepatitis C or HIV * patients who have any of the following diseases; Sepsis, Demyelinating disorders, Lymphoproliferative disease, Infection with prosthetic joint, Autoimmune diseases other than rheumatoid arthritis